Pharma News, 2019

GENEVA (Reuters) - Africa could be declared free of endemic “wild” polio early next year if a strain last seen in Nigeria almost three years ago does not resurface, the World Health Organi...

Concentrations of antibiotics found in some of the world's rivers exceed 'safe' levels by up to 300 times, the first ever global study has discovered.

TORONTO/MONTREAL (Reuters) - The Canadian province of British Columbia said on Monday that its public drug plan will switch as many as 20,400 patients from three branded biologic drugs to chea...

Dendreon, which last summer changed ownership for a third time in as many years, signaled its faith in prostate drug Provenge by signing a lease extension for its Seal Beach, California, manufacturing...

Is Daiichi Sankyo following in several Big Pharma companies’ footsteps out the consumer healthcare door? According to the company, the answer is "no.

(Reuters Health) - Fatty liver disease that’s not related to alcohol use is linked with an increased risk of cirrhosis and liver cancer, especially in people with diabetes, according to a la...

You’d be hard-pressed to find someone who’s lost more during the recent upheaval in the generic drug business than Dilip Shanghvi.

When it comes to Invokana sales, Johnson & Johnson needs a way to stop the bleeding.

WuXi Biologics says its vaccine joint venture has a new client and a 20-year arrangement it says should be worth about $3 billion.

(Reuters) - GlaxoSmithKline Plc said on Thursday its shingles vaccine had been approved for use in China in adults aged 50 and above.

(Reuters) - Amgen, the world’s largest biotechnology company, agreed on Wednesday to buy Scandinavian biopharmaceutical company Nuevolution AB for 1.

Instituting combination antiretroviral (ART) treatment at the earliest stages of HIV infection may allow the generation of functional CD8 "killer" T cells and preservation of the CD4...